Sugi Holdings Co (STU:UGI) EBIT: €264 Mil (TTM As of Feb. 2026)


STU:UGI Sugi Holdings Co Ltd STU:UGI
95 GF Score
Price €16.70
GF Value €17.87
! 4 Warning Signs
View Full Analysis

What is Sugi Holdings Co EBIT?

Sugi Holdings Co STU:UGI +3.09% 95 EBIT is €264 Mil as of Feb. 2026. GuruFocus rates STU:UGI with a GF Score™ of 95/100 and a GF Value™ of €17.87. The stock has 4 warning signs investors should review.

Sugi Holdings Co's earnings before interest and taxes (EBIT) for the three months ended in Feb. 2026 was €69 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Feb. 2026 was €264 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Sugi Holdings Co's annualized ROC % for the quarter that ended in Feb. 2026 was 11.35%. Sugi Holdings Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2026 was 40.38%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Sugi Holdings Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Feb. 2026 was 8.98%.


Sugi Holdings Co  (STU:UGI) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Sugi Holdings Co's annualized ROC % for the quarter that ended in Feb. 2026 is calculated as:

ROC % (Q: Feb. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Nov. 2025 ) + Invested Capital (Q: Feb. 2026 ))/ count )
=314.92 * ( 1 - 24.44% )/( (2135.8 + 2055.611)/ 2 )
=237.953552/2095.7055
=11.35 %

where

Invested Capital(Q: Nov. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3433.854 - 923.398 - ( 602.346 - max(0, 1342.842 - 1717.498+602.346))
=2135.8

Invested Capital(Q: Feb. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3351.745 - 862.818 - ( 606.616 - max(0, 1263.543 - 1696.859+606.616))
=2055.611

Note: The Operating Income data used here is four times the quarterly (Feb. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Sugi Holdings Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Feb. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Feb. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Nov. 2025  Q: Feb. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=275.692/( ( (693.216 + max(-77.93, 0)) + (672.419 + max(-26.863, 0)) )/ 2 )
=275.692/( ( 693.216 + 672.419 )/ 2 )
=275.692/682.8175
=40.38 %

where Working Capital is:

Working Capital(Q: Nov. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(421.011 + 566.021 + 128.12) - (923.398 + 0 + 269.684)
=-77.93

Working Capital(Q: Feb. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(395.314 + 515.122 + 179.807) - (862.818 + 0 + 254.288)
=-26.863

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Feb. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Sugi Holdings Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Feb. 2026 )
=264.125/2942.259
=8.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sugi Holdings Co EBIT Related Terms


Sugi Holdings Co EBIT Historical Data

* Premium members only.

The historical data trend for Sugi Holdings Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sugi Holdings Co EBIT Chart

Sugi Holdings Co Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 209.98 197.97 198.99 242.62 251.18

Sugi Holdings Co Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.53 67.38 67.39 60.43 68.92

Sugi Holdings Co EBIT Competitor Comparison

For the Pharmaceutical Retailers subindustry, Sugi Holdings Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sugi Holdings Co EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sugi Holdings Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sugi Holdings Co's EV-to-EBIT falls into.


STU:UGI
95GF Score
Sugi Holdings Co Ltd STU:UGI
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sugi Holdings Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €264 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €264 Mil mean?
Sugi Holdings Co (STU:UGI) has a EBIT of €264 Mil as of Feb. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Sugi Holdings Co.
Is Sugi Holdings Co's EBIT too high?
Sugi Holdings Co's current EBIT is €264 Mil. Overall, Sugi Holdings Co has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does Sugi Holdings Co's EBIT compare to competitors?
Sugi Holdings Co's EBIT of €264 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Sugi Holdings Co. Sugi Holdings Co's current EBIT is €264 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sugi Holdings Co stock overvalued right now?
Sugi Holdings Co (STU:UGI) has a current EBIT of €264 Mil. The stock's GF Value™ is €17.87, compared to a current price of €16.70 — trading 6.5% below its estimated fair value. The current EBIT is €264 Mil. Sugi Holdings Co's overall GF Score™ is 95/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Sugi Holdings Co (STU:UGI), the current EBIT is €264 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sugi Holdings Co (STU:UGI) Overvalued in 2026?

Based on GuruFocus' analysis, Sugi Holdings Co stock appears to be undervalued. The current stock price of €16.70 is trading 6.5% below its estimated GF Value™ of €17.87.

Key valuation signals for STU:UGI:

  • EBIT: €264 Mil
  • GF Value™: €17.87 vs. price of €16.70 (6.5% below fair value)
  • GF Score™: 95/100 with 4 warning signs

No single metric tells the full story. See the STU:UGI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sugi Holdings Co Business Description

Other Exchanges 7649:JapanUGI:Germany
Address 62-1 Shine, Yokone-cho, Aichi Prefecture, Obu, JPN, 474-0011
Sugi Holdings Co Ltd is a Japan-based company engaged in drugstore operations and the pharmaceutical dispensing business. Through its subsidiaries, the company is involved in selling pharmaceuticals, health foods, cosmetics, daily essentials, and prescription drugs. It also operates community-based drugstores that support home healthcare in collaboration with local medical professionals. The company also supports regional healthcare facilities and provides at-home nursing services.
95GF Score

Get the complete analysis for STU:UGI

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€16.70
Price
€17.87
GF Value